Diclofenac Sodium/Tolperisone Hydrochloride

双氯芬酸钠/盐酸甲哌酮

Report date: 2022/03/15 13:52:44

Base Information

Drug NameDiclofenac Sodium/Tolperisone Hydrochloride
Drug Alias Name甲哌酮+双氯芬酸Tolperisone/diclofenaDiclofenac/tolperisone甲哌酮/双氯芬酸双氯芬酸钠+盐酸甲哌酮 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsVoltage-gated calcium channel blockersSodium channel alpha subunit blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channelCyclooxygenases
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Diclofenac SodiumTolperisone Hydrochloride
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInventia Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInventia Healthcare Ltd
Active IndicationsN/A
Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A